The histotypes of the tumors from female dog used in the study.

<p>The histotypes of the tumors from female dog used in the study.</p

Number of implanted CapCell and dosage of cyclophosphamide in the study group.

<p>Number of implanted CapCell and dosage of cyclophosphamide in the study group.</p

Close up of a capsule, revealing living HEK293 cells inside.

<p>Close up of a capsule, revealing living HEK293 cells inside.</p

Dosage of cyclophosphamide in the control group.

<p>Dosage of cyclophosphamide in the control group.</p

Section through the tumour and capsules after resection.

<p>Capsules, which have been deformed into elongated shapes by the sectioning, and the outer layer of tumour tissue are visible.</p

Results of cytology in female dog X, Papanicolaou staining, mag, x 400.

<p>Results of cytology in female dog X, Papanicolaou staining, mag, x 400.</p

Dynamics of tumour size changes in the study group.

<p>Dynamics of tumour size changes in the study group.</p

Dynamics of tumour size change in the study group expressed as a percentage of initial tumour size.

<p>Dynamics of tumour size change in the study group expressed as a percentage of initial tumour size.</p

Therapeutic efficiency of general administration of cyclophosphamide in the control group.

<p>Therapeutic efficiency of general administration of cyclophosphamide in the control group.</p

Results of cytology in XIII female dog Papanicolaou staining staining, mag, x 400.

<p>Results of cytology in XIII female dog Papanicolaou staining staining, mag, x 400.</p